TITLE

Endocrinology & metabolism

PUB. DATE
August 1997
SOURCE
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS20
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Presents an abstract of the research manuscript `Effects of radiotherapy and the antiestrogen EM-800 alone or in combination on the growth of ZR-75-1 human mammary carcinoma in nude mice,' by S. Couillard, M. Gutman et al from the Laval University.
ACCESSION #
9708235945

 

Related Articles

  • Antiestrogens and Breast Cancer Treatment. Carbone, Paul P. // Annals of Internal Medicine;Nov75, Vol. 83 Issue 5, p730 

    Talks about antiestrogen and breast cancer treatment. Information on estrogen hormone receptors; Substances useful as experimental inhibitors of estrogen action.

  • The role of antiestrogens in the treatment and prevention of breast cancer. Reddy, Prabashni; DeFusco and prevention of breast cancer, Patricia // Formulary;Aug98, Vol. 33 Issue 8, p744 

    Looks at the effectiveness of antiestrogens in the treatment and prevention of breast cancer. Tamoxifen citrate as the hormonal agent of choice for adjuvant therapy following surgery; Risk of endometrial cancer as a potential concern with the use of tamoxifen; Binding of antiestrogens to the...

  • Hormonal therapy of breast cancer: new approaches and concepts. Legha, Sewa S.; Davis, Hugh L.; Muggia, Franco M.; Legha, S S; Davis, H L; Muggia, F M // Annals of Internal Medicine;Jan78, Vol. 88 Issue 1, p69 

    The most useful new hormonal therapy against estrogen receptor-containing metastatic breast cancer is the development of antiestrogenic agents such as nafoxidine and tamoxifen. Both of these drugs possess antitumor activity comparable to that of other additive hormonal agents, and they are...

  • Changes in Vascularization of Human Breast Cancer Xenografts Responding to Antiestrogen Therapy. Kristensen, Claus A; Hamberg, Leena M; Hunter, George J; Roberge, Sylvie; Kierstead, Diane; Wolf, Gerald L; Jain, Rakesh K // Neoplasia;Dec99, Vol. 1 Issue 6, p518 

    To elucidate the previously suggested vascular effect(s) of antiestrogen therapy, we studied the effect of estrogen withdrawal and tamoxifen on 1) vascular resistance, 2) glucose and oxygen consumption, and 3) vascular density in a perfused breast cancer line (ZR75-1). Furthermore, we examined...

  • Opinion: Anti-oestrogenic prevention of breast cancer — the make or break point. Powles, Trevor J. // Nature Reviews Cancer;Oct2002, Vol. 2 Issue 10, p787 

    Clinical trials have shown that giving anti-oestrogens to healthy women can reduce the early incidence of breast cancer by ∼40%. However, the large numbers of women treated, compared with the few who get breast cancer, together with the not insignificant toxicity and the unknown long-term...

  • Anti-estrogen therapy associated with reduced risk for death from lung cancer. Fisher, Stacey L.; Shafer, Emily; Volansky, Rob // Hem/Onc Today;3/10/2011, Vol. 12 Issue 5, p38 

    The article discusses a research study published in "The Cancer Journal," which found an association between anti-estrogen therapy for the treatment of breast cancer and a reduced risk for death from lung cancer.

  • Fulvestrant: A Viewpoint by Roger W. Blamey. Blamey, R.W. // Drugs;Apr2001, Vol. 61 Issue 6, p814 

    Presents information on fulvestrant, an anti-estrogen antagonist, indicated for treating breast cancer. Comparison between fulvestrant and tamoxifen as estrogen receptors; Limitations of the effect of the fulvestrant.

  • Fulvestrant. Curran, M.; Wiseman, L. // Drugs;Apr2001, Vol. 61 Issue 6, p807 

    ▴ Fulvestrant is a 7α-alkylsulphinyl analogue of estradiol that competes with endogenous estrogen for binding to the estrogen receptor. Once bound to the receptor, fulvestrant attenuates receptor dimerisation, effecting a rapid degradation of the estrogen receptor protein and inhibition...

  • Tamoxifen: In whose best interest? Oakley, Ann // New Scientist;6/22/91, Vol. 130 Issue 1774, p12 

    Discusses the issues involved in the trials of tamoxifen for the treatment of breast cancer. Study by Trevor Powles of the Royal Marsden Hospital in England; Statistics of breast cancer in the UK; Need for women in the study to be given clear and complete information about the drug; History of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics